FeirenSangza (Talk | contribs) |
FeirenSangza (Talk | contribs) |
||
Line 161: | Line 161: | ||
<li> We proved that our central part <a href="http://parts.igem.org/Part:BBa_K2200010">BBa_K2200010 </a> worked as expected and submitted the part tothe iGEM Parts Registry.</li> | <li> We proved that our central part <a href="http://parts.igem.org/Part:BBa_K2200010">BBa_K2200010 </a> worked as expected and submitted the part tothe iGEM Parts Registry.</li> | ||
<li> We made lots of <a href="https://2017.igem.org/Team:Shenzhen_SFLS/ Collaborations "> Collaborations </a> with other teams!</li> | <li> We made lots of <a href="https://2017.igem.org/Team:Shenzhen_SFLS/ Collaborations "> Collaborations </a> with other teams!</li> | ||
− | <li>We enhanced the public attention toward skin cancer and dealt with the public misunderstanding toward genetic therapy and diseases. More details for <a href=" | + | <li>We enhanced the public attention toward skin cancer and dealt with the public misunderstanding toward genetic therapy and diseases. More details for <a href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver">silver HP </a>. </li> |
</div> | </div> | ||
Line 172: | Line 172: | ||
<img src="https://static.igem.org/mediawiki/2017/b/bf/Sfls-achi-gold.svg"> | <img src="https://static.igem.org/mediawiki/2017/b/bf/Sfls-achi-gold.svg"> | ||
− | <li>We investigated the problems existing in society for the direction of our project. Also, we communicated with experts and other iGEM teams to resolve the trouble we met. More details for <a href=" | + | <li>We investigated the problems existing in society for the direction of our project. Also, we communicated with experts and other iGEM teams to resolve the trouble we met. More details for <a href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated">Integrated HP</a>.</li> |
<li>We <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Improve">improved</a> part <a href="http://parts.igem.org/Part:BBa_K1470002"> BBa_K1470002 </a>. </li> | <li>We <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Improve">improved</a> part <a href="http://parts.igem.org/Part:BBa_K1470002"> BBa_K1470002 </a>. </li> | ||
− | <li>We designed our <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Design"> Regulatory System </a> based on insight we had gained from<a href="https://2017.igem.org/Team:Shenzhen_SFLS/Model">modeling</a>.</li> | + | <li>We designed our <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Design"> Regulatory System </a> based on insight we had gained from <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Model">modeling</a>.</li> |
<li>We <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Demonstrate"> demonstrated </a> our CRISPR/Cas9 system in melanoma cell lines. </li> | <li>We <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Demonstrate"> demonstrated </a> our CRISPR/Cas9 system in melanoma cell lines. </li> | ||
</div> | </div> | ||
Line 194: | Line 194: | ||
<li style="text-align:left;">We investigated the problems existing in society for the direction of our project. Also, we communicated with experts and other iGEM teams to resolve the trouble we met. More details for <a href=" https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated">Integrated HP</a>.</li> | <li style="text-align:left;">We investigated the problems existing in society for the direction of our project. Also, we communicated with experts and other iGEM teams to resolve the trouble we met. More details for <a href=" https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated">Integrated HP</a>.</li> | ||
− | <li style="text-align:left;">We enhanced the public attention toward skin cancer and dealt with the public misunderstanding toward genetic therapy and diseases. More details for <a href=" | + | <li style="text-align:left;">We enhanced the public attention toward skin cancer and dealt with the public misunderstanding toward genetic therapy and diseases. More details for <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Engagement"> Public engagement </a>. </li> |
Revision as of 03:21, 2 November 2017
MEDAL CRITERIA
BRONZE
SILVER
GOLD
AWARDS